TY - JOUR
KW - Humans
KW - *Diabetes Mellitus, Type 2/drug therapy
KW - *Bisoprolol/therapeutic use
KW - *Antihypertensive Agents/therapeutic use/adverse effects
KW - Female
KW - Middle Aged
KW - *Hypertension/epidemiology/drug therapy
KW - Male
KW - Aged
KW - Cohort Studies
KW - Incidence
KW - Bias
KW - Risk Assessment/methods
KW - Adult
KW - Cprd
KW - Ipcw
KW - Type 2 diabetes mellitus
KW - Antihypertensive therapy
KW - bisoprolol
KW - censoring bias
KW - real-world evidence
AU - A. Pinon
AU - A. Allignol
AU - T. Hohenberger
AU - C. Foch
AU - E. Boutmy
AU - U. Hostalek
AD - Arthur Allignol & Antoine Pinon were employed by Merck Healthcare KGaA, Darmstadt, Germany.
Merck Healthcare KGaA, Darmstadt, Germany.
AN - 39417364
BT - J Comp Eff Res
C2 - PMC11542089
DO - 10.57264/cer-2023-0027
DP - NLM
ET - 2024/10/17
LA - eng
M1 - 11
N1 - 2042-6313
Pinon, Antoine
Orcid: 0000-0001-9305-0645
Allignol, Arthur
Orcid: 0000-0002-2362-0072
Hohenberger, Thilo
Foch, Caroline
Orcid: 0000-0002-0254-5560
Boutmy, Emmanuelle
Orcid: 0000-0001-9657-9376
Hostalek, Ulrike
Comparative Study
Journal Article
England
J Comp Eff Res. 2024 Nov;13(11):e230027. doi: 10.57264/cer-2023-0027. Epub 2024 Nov 17.
PY - 2024
SN - 2042-6305 (Print)2042-6305
EP - e230027
T2 - J Comp Eff Res
TI - Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practice Research Datalink cohort study
VL - 13
ER -